Theravance Biopharma (TBPH) Prepaid Assets (2013 - 2026)

Theravance Biopharma (TBPH) has 14 years of Prepaid Assets data on file, last reported at $7.4 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $7.4 million, up 82.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.4 million (up 82.05% YoY), and the FY2025 annual result was $7.6 million, up 76.85% from the prior year.
• Prepaid Assets declined to $7.4 million in Q1 2026 per TBPH's latest filing, from $7.6 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $11.6 million in Q4 2023 and troughed at $4.1 million in Q1 2025.
• A 5-year average of $7.0 million and a median of $7.4 million in 2026 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2024 and 2026: Prepaid Assets sank 63.14% in 2024, then soared 82.05% in 2026.
• A 5-year view of Prepaid Assets shows it stood at $7.7 million in 2022, then surged by 51.04% to $11.6 million in 2023, then slumped by 63.14% to $4.3 million in 2024, then soared by 76.85% to $7.6 million in 2025, then retreated by 2.38% to $7.4 million in 2026.
• Business Quant data shows TBPH's Prepaid Assets at $7.4 million in Q1 2026, $7.6 million in Q4 2025, and $6.8 million in Q3 2025.